Transitioning From Vial To Prefilled Syringe: How Formulation Development Affects Manufacturing
Source: Catalent
By Natasha Van Rutten, Product Development Director, Catalent Biologics
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Catalent
This website uses cookies to ensure you get the best experience on our website. Learn more